XML 20 R6.htm IDEA: XBRL DOCUMENT v3.21.2
Consolidated Statement of Changes in Stockholders' Equity (Unaudited) - USD ($)
Public Stock Offering [Member]
Common Stock [Member]
Public Stock Offering [Member]
Additional Paid-in Capital [Member]
Public Stock Offering [Member]
Private Placement [Member]
Common Stock [Member]
Private Placement [Member]
Additional Paid-in Capital [Member]
Private Placement [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Treasury Stock [Member]
Deferred Compensation, Share-based Payments [Member]
Retained Earnings [Member]
Total
Balance (in shares) at Dec. 31, 2019             18,224,577          
Balance at Dec. 31, 2019             $ 186,656 $ 77,055,273 $ (1,885,452) $ (5,636,154) $ (62,151,988) $ 7,568,335
Issuance of common stock under equity incentive plan (in shares)             51,000          
Issuance of common stock under equity incentive plan             $ 51 59,440       59,491
Warrant compensation costs               8,985       8,985
Deferred compensation amortization                   228,219   228,219
Purchase of treasury stock costs                 (26,629)     (26,629)
Net income (loss) for the period                     (835,009) (835,009)
Balance at Mar. 31, 2020             $ 186,707 77,123,698 (1,912,081) (5,407,935) (62,986,997) 7,003,392
Balance (in shares) at Mar. 31, 2020             18,275,577          
Balance (in shares) at Dec. 31, 2019             18,224,577          
Balance at Dec. 31, 2019             $ 186,656 77,055,273 (1,885,452) (5,636,154) (62,151,988) 7,568,335
Net income (loss) for the period                       (3,059,195)
Balance at Sep. 30, 2020             $ 194,318 88,392,782 (2,065,763) (5,793,116) (65,211,183) 15,517,038
Balance (in shares) at Sep. 30, 2020             25,887,785          
Balance (in shares) at Mar. 31, 2020             18,275,577          
Balance at Mar. 31, 2020             $ 186,707 77,123,698 (1,912,081) (5,407,935) (62,986,997) 7,003,392
Issuance of common stock under equity incentive plan (in shares)             1,500,544          
Issuance of common stock under equity incentive plan             $ 1,500 1,641,304   (1,559,520)   83,284
Warrant compensation costs               8,988       8,988
Deferred compensation amortization                   267,207   267,207
Purchase of treasury stock costs                 (55,819)     (55,819)
Net income (loss) for the period                     (1,288,169) (1,288,169)
Balance at Jun. 30, 2020             $ 188,207 78,773,990 (1,967,900) (6,700,248) (64,275,166) 6,018,883
Balance (in shares) at Jun. 30, 2020             19,776,121          
Issuance of common stock under equity incentive plan (in shares)             32,323          
Issuance of common stock under equity incentive plan             $ 32 149,961       149,993
Warrant compensation costs               8,985       8,985
Cashless warrant exercise (in shares)             27,051          
Cashless warrant exercise             $ 27 (27)        
Reversal of deferred compensation amortization that did not vest (in shares)             (450,000)          
Reversal of deferred compensation amortization that did not vest             $ (450) (791,550)   594,900   (197,100)
Deferred compensation amortization                   312,232   312,232
Purchase of treasury stock costs                 (97,863)     (97,863)
Net income (loss) for the period                     (936,017) (936,017)
Balance at Sep. 30, 2020             $ 194,318 88,392,782 (2,065,763) (5,793,116) (65,211,183) 15,517,038
Issuance of common stock (in shares) 4,705,883     1,796,407                
Issuance of common stock $ 4,705 $ 7,253,220 $ 7,257,925 $ 1,797 $ 2,998,203 $ 3,000,000            
Balance (in shares) at Sep. 30, 2020             25,887,785          
Balance (in shares) at Dec. 31, 2020             26,260,776          
Balance at Dec. 31, 2020             $ 194,692 89,659,433 (2,165,721) (5,926,872) (65,058,171) 16,703,361
Issuance of common stock under equity incentive plan (in shares)             51,000          
Issuance of common stock under equity incentive plan             $ 51 120,484       120,535
Warrant compensation costs               8,985       8,985
Cashless warrant exercise (in shares)             19,795          
Cashless warrant exercise             $ 19 (19)        
Reversal of deferred compensation amortization that did not vest (in shares)             (17,111)          
Reversal of deferred compensation amortization that did not vest             $ (17) (48,599)   5,994   (42,622)
Deferred compensation amortization                   249,801   249,801
Purchase of treasury stock costs                 (49,454)     (49,454)
Net income (loss) for the period                     (720,252) (720,252)
Balance at Mar. 31, 2021             $ 194,745 89,740,284 (2,215,175) (5,671,077) (65,778,423) 16,270,354
Balance (in shares) at Mar. 31, 2021             26,314,460          
Balance (in shares) at Dec. 31, 2020             26,260,776          
Balance at Dec. 31, 2020             $ 194,692 89,659,433 (2,165,721) (5,926,872) (65,058,171) 16,703,361
Net income (loss) for the period                       (360,535)
Balance at Sep. 30, 2021             $ 194,746 89,702,612 (2,364,071) (4,954,584) (65,418,706) 17,159,997
Balance (in shares) at Sep. 30, 2021             26,289,288          
Balance (in shares) at Mar. 31, 2021             26,314,460          
Balance at Mar. 31, 2021             $ 194,745 89,740,284 (2,215,175) (5,671,077) (65,778,423) 16,270,354
Issuance of common stock under equity incentive plan (in shares)             61,556          
Issuance of common stock under equity incentive plan             $ 61 150,481       150,542
Warrant compensation costs               8,985       8,985
Reversal of deferred compensation amortization that did not vest (in shares)             (115,000)          
Reversal of deferred compensation amortization that did not vest             $ (115) (237,085)   158,096   (79,104)
Deferred compensation amortization                   245,847   245,847
Purchase of treasury stock costs                 (29,810)     (29,810)
Net income (loss) for the period                     218,483 218,483
Balance at Jun. 30, 2021             $ 194,691 89,662,665 (2,244,985) (5,267,134) (65,559,940) 16,785,297
Balance (in shares) at Jun. 30, 2021             26,261,016          
Issuance of common stock under equity incentive plan (in shares)             49,322          
Issuance of common stock under equity incentive plan             $ 76 108,146       129,007
Warrant compensation costs               8,985       8,985
Cashless warrant exercise (in shares)             19,950          
Cashless warrant exercise             $ 20 (20)        
Reversal of deferred compensation amortization that did not vest (in shares)             (41,000)          
Reversal of deferred compensation amortization that did not vest             $ (41) (77,164)   52,434   (24,771)
Deferred compensation amortization                   239,331   239,331
Purchase of treasury stock costs                 (119,086)     (119,086)
Net income (loss) for the period                     141,234 141,234
Balance at Sep. 30, 2021             $ 194,746 $ 89,702,612 $ (2,364,071) $ (4,954,584) $ (65,418,706) $ 17,159,997
Balance (in shares) at Sep. 30, 2021             26,289,288